View in EDS

Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series.

Saved in:
Bibliographic Details
Title: Interleukin-1 receptor antagonist anakinra as treatment for paradoxical responses in HIV-negative tuberculosis patients: A case series.
Authors: van Arkel C; Department of Pulmonary Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands; Department of Pulmonary Diseases, Catharina Hospital, 5623 EJ Eindhoven, the Netherlands., Boeree M; Department of Pulmonary Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Magis-Escurra C; Department of Pulmonary Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Hoefsloot W; Department of Pulmonary Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Carpaij N; Department of Pulmonary Diseases, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., van Ingen J; Department of Medical Microbiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Pegge S; Department of Radiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Wielders P; Department of Pulmonary Diseases, Catharina Hospital, 5623 EJ Eindhoven, the Netherlands., Smeenk F; Department of Pulmonary Diseases, Catharina Hospital, 5623 EJ Eindhoven, the Netherlands., Aarnoutse R; Department of Pharmacy, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Netea MG; Department of Internal Medicine, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands; Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany., van Crevel R; Department of Internal Medicine, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK., van Laarhoven A; Department of Internal Medicine, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands. Electronic address: arjan.vanlaarhoven@radboudumc.nl.
Source: Med (New York, N.Y.) [Med] 2022 Sep 09; Vol. 3 (9), pp. 603-611.e2. Date of Electronic Publication: 2022 Aug 29.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6340
DOI:10.1016/j.medj.2022.07.001